Literature DB >> 17913932

Molecular typing of a suspected cluster of Nocardia farcinica infections by use of randomly amplified polymorphic DNA, pulsed-field gel electrophoresis, and amplified fragment length polymorphism analyses.

J S Kalpoe1, K E Templeton, A M Horrevorts, H P Endtz, E J Kuijper, A T Bernards, C H W Klaassen.   

Abstract

Randomly amplified polymorphic DNA (RAPD), pulsed-field gelelectrophoresis (PFGE), and amplified fragment length polymorphism (AFLP) analyses were used to investigate a possible outbreak of Nocardia farcinica. RAPD and PFGE analyses yielded irreproducible and unsatisfactory results, respectively. AFLP analysis seem to be a promising and welcome addition for molecular analysis of Nocardia isolates.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17913932      PMCID： PMC2168561          DOI： 10.1128/JCM.00932-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Contagious and other aspects of nocardiosis in the compromised host.

Authors:  F Cox; W T Hughes
Journal:  Pediatrics       Date:  1975-01       Impact factor: 7.124

2.  Comparison of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens.

Authors:  E M D'Agata; M M Gerrits; Y W Tang; M Samore; J G Kusters
Journal:  Infect Control Hosp Epidemiol       Date:  2001-09       Impact factor: 3.254

3.  Comparative evaluation of three different genotyping methods for investigation of nosocomial outbreaks of Legionnaires' disease in hospitals.

Authors:  D Jonas; H G Meyer; P Matthes; D Hartung; B Jahn; F D Daschner; B Jansen
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Amplified fragment length polymorphism fingerprinting is an effective technique to distinguish streptococcus pneumoniae from other Streptococci and an efficient alternative to pulsed-field gel electrophoresis for molecular typing of pneumococci.

Authors:  Chris Neeleman; Corné H W Klaassen; Hanneke A de Valk; Maaike T de Ruiter; Johan W Mouton
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 5.  Nocardiosis: review of clinical and laboratory experience.

Authors:  Michael A Saubolle; Den Sussland
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

6.  Comparison of two highly discriminatory molecular fingerprinting assays for analysis of multiple Aspergillus fumigatus isolates from patients with invasive aspergillosis.

Authors:  Hanneke A de Valk; Jacques F G M Meis; Ben E de Pauw; Peter J Donnelly; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

7.  Experience with Nocardia asteroides in renal transplant recipients.

Authors:  A G Hellyar
Journal:  J Hosp Infect       Date:  1988-07       Impact factor: 3.926

8.  Nocardiosis in recipients of renal transplants: evidence for nosocomial acquisition.

Authors:  L M Baddour; V S Baselski; M J Herr; G D Christensen; A L Bisno
Journal:  Am J Infect Control       Date:  1986-10       Impact factor: 2.918

9.  Nocardia asteroides infection--a transmissible disease.

Authors:  E T Houang; I S Lovett; F D Thompson; A R Harrison; A M Joekes; M Goodfellow
Journal:  J Hosp Infect       Date:  1980-03       Impact factor: 3.926

10.  Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism.

Authors:  Corné H W Klaassen; Hanneke A van Haren; Alfons M Horrevorts
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948
View more
  1 in total

1.  Identification, typing, and phylogenetic relationships of the main clinical Nocardia species in spain according to their gyrB and rpoB genes.

Authors:  Gema Carrasco; Sylvia Valdezate; Noelia Garrido; Pilar Villalón; Maria J Medina-Pascual; Juan A Sáez-Nieto
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.